Skip to main content
AL

Altis Labs

Toronto, Canada
Last funding
$25.0M
Series ASep 2026

Altis is accelerating clinical trials with AI endpoints so that drug developers can get the best new treatment to patients sooner.

Backed byFusion FundOrbiMedLumira VenturesBenchstrengthCreative Destruction Lab

About Altis Labs

How much funding has Altis Labs raised?

Altis Labs has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in September 2026.

Who are Altis Labs's investors?

Altis Labs's investors include Fusion Fund, OrbiMed, Lumira Ventures, Benchstrength, Creative Destruction Lab.

Where is Altis Labs headquartered?

Altis Labs is headquartered in Toronto, Canada.

What does Altis Labs do?

Altis is accelerating clinical trials with AI endpoints so that drug developers can get the best new treatment to patients sooner.

What stage is Altis Labs at?

Altis Labs is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Altis Labs — Funding & Investors." VCBacked, September 17, 2026, https://www.vcbacked.co/company/altis-labs. Accessed November 17, 2026.
APA
VCBacked. (2026). Altis Labs — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/altis-labs
Wikipedia (cite web)
{{cite web |title=Altis Labs — Funding & Investors |url=https://www.vcbacked.co/company/altis-labs |website=VCBacked |access-date=November 17, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Altis Labs? Request a listing update

Founder contacts
m***@altislabs.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →